A few of our phenomenal fellows celebrating with some pickleball after surviving echo boards! Suchith Vuppala Andy Godwin Amanda Heuszel Mark Metzinger, Angel Garcia Charles F. Sherrod IV, M.D., M.Sc. Dan Nguyen Saint Luke's

Healthy vs pathological microvascular aging? New research showing myocardial blood flow reserve is higher in young males compared with females, and decreases with age in both sexes. Saint Luke's Mid America Heart Institute Saint Luke's CircImaging ahajournals.org/doi/10.1161/CI…

Excited to be joining Saint Luke’s Mid America Heart Institute in Kansas City to help care for ACHD patients at the only accredited program in the Missouri/Kansas area Saint Luke's Mid America Heart Institute ACHA

Here are some reasons why you should train with us in Cardiovascular Disease at the University of Missouri-Kansas City School of Medicine program Saint Luke's Mid America Heart Institute Saint Luke's!

Proof I made it to European Society of Cardiology Let’s go! Check out JACC Journals publications our team is releasing soon during London sessions. jacc.org/events/confere… Mikhail Kosiborod John Spertus Saint Luke's Mid America Heart Institute Saint Luke's

Semaglutide and obesity related HFpEF Patients with atrial fibrillation and obesity HFpEF are generally more burdened/congested at baseline and also may benefit more from GLP1 in health status and walking distance. Mikhail Kosiborod Saint Luke's Mid America Heart Institute jacc.org/doi/10.1016/j.…

Inflammation reduction by semaglutide as measured by CRP tracks with magnitude of NTproBNP reduction.

Semaglutide and obesity HFpEF Echo markers Improved LA volume reduction and markers of diastolic function with GLP1 compared to placebo. Muthu Vaduganathan BiykemBozkurt Mikhail Kosiborod

CV outcomes from FLOW trial. Semaglutide vs placebo focused on patients with HF within larger population of T2DM and CKD.

Pooled analysis of patients with HFpEF in STEP-HFpEF, SELECT, and FLOW Mikhail Kosiborod Saint Luke's Mid America Heart Institute Saint Luke's Muthu Vaduganathan

Outside of her work as an oncologist, Dr. Juliet Appiah helps cancer patients in her home country of Ghana. Dr. Appiah spoke with KSHB 41 News about her passion for giving back to her home country and raising awareness for all types of cancer. Watch now: heyor.ca/7WUskq

Art Still, a former Kansas City Chiefs defensive end, has dedicated himself to increasing awareness for ATTR amyloidosis ever since his diagnosis in 2023. TODAY spoke with Dr. Brett Sperry, a Saint Luke's Mid America Heart Institute cardiologist, to discuss the rare genetic condition: heyor.ca/FH3BGP

Star fellow Mirza Khan presenting data on geographic patterns of prescriptions for amyloid medications from EPIC Cosmos at #ACC25 Saint Luke's Mid America Heart Institute

One of the defining aspects of our fellowship are our accomplished alumni. As a part of our fellowship research day, Dr. Chhatriwalla honored us with a noon conference on advancements in ViV TAVR and bioprosthetic valve fracture! Adnan Chhatriwalla venu menon

Understanding patient-reported outcomes in obstructive hypertrophic cardiomyopathy (oHCM) is vital for managing treatment effectively. We recently validated the Kansas City Cardiomyopathy Questionnaire-12 (KCCQ-12) in this population. Here’s why it matters: A quick🧵

At #ESCHF2025 🇷🇸 Saint Luke's Mid America Heart Institute fellow Dr Omar Cantu-Martinez presents #CAREHKinHF real-world registry: >2,300 HF pts w/ hyperK risk with 9% on clinician selected patiromer. Reduced severe HK and trend toward more optimal GDMT. Take-home: early K⁺ control keeps GDMT on &

Grateful for the opportunity to work with Amgen 🧪🔬🧬 in collaboration with Cardiometabolic Center Alliance Saint Luke's Mid America Heart Institute as part of the LATTICE Consortium to address implementation of cardiometabolic therapies and stepping into the gaps.

Special focus issue in JACC Journals this week on Cardiac Amyloidosis. Many important articles! Sharing my editorial with Joban Vaishnav from Johns Hopkins University sciencedirect.com/journal/journa…

Congratulations to Rich Liekweg, BJC Health System CEO, who announced his plans to retire on October 1, 2025. BJC is pleased to announce that Nick Barto, current BJC Health System President, will succeed Rich as President and CEO of BJC Health System: heyor.ca/j1yUMR